M3-Brigade Acquisition V (NASDAQ:MBAV) Announces Earnings Results

M3-Brigade Acquisition V (NASDAQ:MBAV) issued its earnings results on Thursday. The company reported $0.05 EPS for the quarter, FiscalAI reports.

M3-Brigade Acquisition V Stock Performance

MBAV stock traded down $0.02 during midday trading on Friday, hitting $10.80. The company had a trading volume of 2,685 shares, compared to its average volume of 34,945. M3-Brigade Acquisition V has a 52 week low of $10.41 and a 52 week high of $13.73. The stock’s 50 day moving average price is $10.78 and its 200 day moving average price is $10.70.

Institutional Investors Weigh In On M3-Brigade Acquisition V

Institutional investors have recently modified their holdings of the business. Saba Capital Management L.P. bought a new stake in shares of M3-Brigade Acquisition V during the 4th quarter valued at about $151,000. Hudson Bay Capital Management LP purchased a new position in M3-Brigade Acquisition V during the fourth quarter worth $159,000. Prelude Capital Management LLC purchased a new stake in M3-Brigade Acquisition V in the 3rd quarter worth about $281,000. Sandia Investment Management LP bought a new stake in shares of M3-Brigade Acquisition V during the 2nd quarter worth approximately $334,000. Finally, Radcliffe Capital Management L.P. bought a new position in shares of M3-Brigade Acquisition V in the third quarter worth about $544,000.

Wall Street Analysts Forecast Growth

Several equities research analysts recently issued reports on MBAV shares. Weiss Ratings reiterated a “sell (d)” rating on shares of M3-Brigade Acquisition V in a report on Friday, March 27th. Wall Street Zen upgraded shares of M3-Brigade Acquisition V to a “sell” rating in a research note on Saturday, March 14th. One investment analyst has rated the stock with a Sell rating, According to MarketBeat.com, the company presently has a consensus rating of “Sell”.

M3-Brigade Acquisition V Company Profile

M3-Brigade Acquisition V is a special purpose acquisition company (SPAC) sponsored by M3 Inc, a global healthcare information and technology provider, and Brigade Capital Management, an investment management firm. The company is structured as a blank‐check vehicle listed on the Nasdaq Stock Market under the ticker MBAV, with the objective of identifying and completing a business combination in the healthcare, life sciences or related sectors.

The company benefits from the operational expertise of M3’s digital health platform and real‐world data capabilities, combined with Brigade’s deep experience in credit and asset management.